Aziz Sawaf - Apr 2, 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP & CHIEF FINANCIAL OFFICER
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Apr 2, 2024
Transactions value $
$0
Form type
4
Date filed
4/4/2024, 06:15 PM
Previous filing
Feb 22, 2024
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Award $0 +100K +41.9% $0.00 339K Apr 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.